Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
ClearSight
ClearSight Innovations Ltd develops ophthalmic diagnostic technologies for cataract surgeries.
Sector
Subsector
Keywords
Location
total rounds
ArcScan
ArcScan develops smart imaging technology and continually evolving ultrasound to help ophthalmologists.
Sector
Subsector
Keywords
Location
total rounds
total raised
2Eyes Vision
2Eyes Vision creates and develops technologies for visual diagnostics and corrections, with a focus on treating presbyopia.
Sector
Subsector
Location
total rounds
total raised
BcnInnova
BcnInnova is a Barcelona-based start-up that uses computer vision to provide medical solutions.
Sector
Subsector
Keywords
Location
M&A Details1
Financials
Funding Rounds10
Number of Funding Rounds
Money Raised
Their latest funding was raised on 06.03.2014. Their latest round Venture - Series Unknown
Foresite Capital
Foresite Capital is a healthcare and life sciences investment firm with $2 billion under management.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors7
Number of lead investors
Number of investors
Versant Ventures
Versant Ventures is a healthcare investment firm that helps entrepreneurs build great companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Foresite Capital
Foresite Capital is a healthcare and life sciences investment firm with $2 billion under management.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Jim Tananbaum
Dr. Tananbaum is the founding CEO of Foresite Capital Management. He has led investments in 21 successful healthcare companies, including Amira Pharmaceuticals (acquired by Bristol-Myers Squibb), Amerigroup and Jazz Pharmaceuticals. Previously, Dr. Tananbaum founded and held management positions at GelTex Pharmaceuticals (acquired by Genzyme for $1.6B) and Theravance. He holds an M.D. from Harvard Medical School and an M.B.A from Harvard Business School, and a B.S. and B.S.E.E. from Yale University. Dr. Tananbaum has served on the advisory boards and/or visiting committees to the Harvard-MIT HST program and Yale School of Engineering.
current job
organization founded
Accuitive Medical Ventures
Accuitive Medical Ventures is a Georgia-based venture capital firm that invests in early-stage medical device and technology companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Anthony Lando
Anthony is our co-founder and has served as Chief Executive Officer and Board member since the inception of SEBACIA in 2010. Anthony is also CEO of The Innovation Factory and previously served as Chief Operating Officer of BTG plc, a UK public-listed specialty pharmaceutical company. Anthony's extensive experience includes operations, product development, intellectual property management, financial management, and fundraising for both public and private companies, as well as development and creation of technology-based entities. Prior positions include leadership roles in marketing, sales, and engineering with Philips Medical Systems and Stone & Webster Engineering. Anthony has managed successful investments in and served on the boards of AqueSys Inc., Wave Tec Vision®, Halscion Inc (keloid scar treatment), and Primaxis Technology Ventures, Inc. He lives in Suwanee, Georgia with his wife, daughter and Elvis...their black labradoodle.
current job
People
Employee Profiles7
Craig Bender
Vice President, Research & Development
